Catalyst

Slingshot members are tracking this event:

TG Therapeutics plans to present top-line overall response rate results from their UNITY-CLL Phase 3 trial in both front line and relapsed or refractory CLL in 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TGTX

100%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Tg-1101, Tgr-1202, Chronic Lymphocytic Leukemia, Non-hodgkin’s Lymphoma, Nhl, Unity-cll, Phase 3 Topline Data